Drizzy Secures Pre-Seed Funding From RiverPark Ventures Nucleus Ventures And Alexis Ohanian

Drizzy (@GetDrizzy), the Sydney-founded peanut butter brand now headquartered in the U.S. and Australia, has announced its American launch alongside a pre-seed funding round backed by investors including RiverPark Ventures, Nucleus Ventures and Alexis Ohanian. Founded by Australian entrepreneurs Jason Spyrides and Georgia Park, Drizzy is reimagining the peanut butter category with its signature premium squeeze-bottle format, made from American-grown peanuts and a splash of peanut oil. Free from added sugar, palm oil, stabilizers, and emulsifiers, the brand was built on the belief that healthy eating should be simple, clean, convenient, and transparent. By combining thoughtful product design with minimal ingredients, Drizzy is modernizing one of America's most-loved pantry staples for the way people eat today. FUN FACT: Peanut butter is a staple in nearly 95% of American households, but the experience hasn't evolved. After one too many messy smoothie mornings, they asked a simple question: if honey, ketchup and mayonnaise all come in squeeze bottles, why doesn't peanut butter? That question became Drizzy. FOUNDERS: Jason Spyrides (@JasonSpyrides) & Georgia Park (@GeorgiaPark1) INVESTORS: RiverPark Ventures, Nucleus Ventures & Alexis Ohanian HQ: USA & Australia #VentureCapital #Drizzy #TradedPartner #TradedVC

More Deals

View All

Colossal Biosciences In Talks For Funding Round Targeting $23 Billion ValuationColossal Biosciences, the de-extinction biotech startup known for its efforts to recreate the woolly mammoth and other extinct species, is reportedly in talks to raise new funding at a valuation of roughly $23 billion–$24 billion, according to Axios. The potential raise would mark a significant jump for the five-year-old company, with investors valuing not only its genetic-engineering programs but also its broader genomics, reproductive technology, conservation, and intellectual property platform. Colossal has begun generating revenue through conservation technology sales and technology spinouts, including Astromech, an AI-driven predictive modeling company, and Form Bio, a computational biology platform, expanding its value beyond de-extinction efforts. FOUNDERS: Ben Lamm & George Church TARGET VALUATION: $23,000,000,000 HQ: Dallas, Texas #VentureCapital #ColossalBiosciences #BenLamm #GeorgeChurch #TradedVC